المؤلفون: Bauer-Smith H; School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK; Centre for Cancer Immunology, School of Cancer Sciences, University of Southampton Faculty of Medicine, Southampton SO16 6YD, UK., Sudol ASL; School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK., Beers SA; Centre for Cancer Immunology, School of Cancer Sciences, University of Southampton Faculty of Medicine, Southampton SO16 6YD, UK. Electronic address: s.a.beers@soton.ac.uk., Crispin M; School of Biological Sciences, University of Southampton, Southampton SO17 1BJ, UK. Electronic address: max.crispin@soton.ac.uk.

المصدر: Biochimica et biophysica acta. General subjects [Biochim Biophys Acta Gen Subj] 2023 Nov; Vol. 1867 (11), pp. 130448. Date of Electronic Publication: 2023 Aug 29.

نوع المنشور: Journal Article; Review; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101731726 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-8006 (Electronic) Linking ISSN: 03044165 NLM ISO Abbreviation: Biochim Biophys Acta Gen Subj Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Fc* , Immunoglobulin G*/metabolism, Receptors, IgG/metabolism ; Immunoglobulin Fc Fragments/metabolism ; Glycosylation

المؤلفون: Chen Q; Structural Biology Science Technology Platform, The Francis Crick Institute, London, UK., Menon RP; Immune Receptor Activation Laboratory, The Francis Crick Institute, London, UK., Masino L; Structural Biology Science Technology Platform, The Francis Crick Institute, London, UK., Tolar P; Immune Receptor Activation Laboratory, The Francis Crick Institute, London, UK. p.tolar@ucl.ac.uk.; Institute of Immunity and Transplantation, University College London, London, UK. p.tolar@ucl.ac.uk., Rosenthal PB; Structural Biology of Cells and Viruses Laboratory, The Francis Crick Institute, London, UK. Peter.Rosenthal@crick.ac.uk.

المصدر: Nature structural & molecular biology [Nat Struct Mol Biol] 2023 Jul; Vol. 30 (7), pp. 1033-1039. Date of Electronic Publication: 2023 Apr 24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101186374 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-9985 (Electronic) Linking ISSN: 15459985 NLM ISO Abbreviation: Nat Struct Mol Biol Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Fc*/metabolism , B-Lymphocytes*/metabolism, Humans ; Immunoglobulin Fc Fragments ; Immunoglobulin M/metabolism ; Binding Sites

المؤلفون: Liang Y; School of Basic Medical Sciences, Shandong Second Medical University, Weifang, China., Xiao W; School of Basic Medical Sciences, Shandong Second Medical University, Weifang, China., Peng Y; School of Clinical Medicine, Shandong Second Medical University, Weifang, China., Zhang S; School of Life Science and Technology, Shandong Second Medical University, Weifang, China., Dong J; School of Rehabilitation Sciences and Engineering, University of Health and Rehabilitation Sciences, Qingdao, China; International Research Frontiers Initiative, Tokyo Institute of Technology, Yokohama, Japan., Zhao J; Peking University Institute of Advanced Agricultural Sciences, Shandong Laboratory of Advanced Agriculture Sciences in Weifang, Weifang, Shandong, 261325, China., Wang Y; School of Clinical Medicine, Shandong Second Medical University, Weifang, China., Zhang M; School of Life Science and Technology, Shandong Second Medical University, Weifang, China., Liu Z; School of Basic Medical Sciences, Shandong Second Medical University, Weifang, China. Electronic address: zhijun.liu@sdsmu.edu.cn., Yu B; School of Basic Medical Sciences, Shandong Second Medical University, Weifang, China. Electronic address: yubowen@sdsmu.edu.cn.

المصدر: Antiviral research [Antiviral Res] 2024 Jul; Vol. 227, pp. 105917. Date of Electronic Publication: 2024 May 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 8109699 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-9096 (Electronic) Linking ISSN: 01663542 NLM ISO Abbreviation: Antiviral Res Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/prevention & control , COVID-19*/immunology , COVID-19 Vaccines*/immunology , Immunoglobulin Fc Fragments*/immunology , Immunoglobulin Fc Fragments*/chemistry , Nanovaccines* , Spike Glycoprotein, Coronavirus*/immunology , Spike Glycoprotein, Coronavirus*/chemistry, Animals ; Female ; Humans ; Mice ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Immunity, Cellular ; Immunogenicity, Vaccine ; Mice, Inbred BALB C ; Protein Binding ; Protein Multimerization ; Recombinant Fusion Proteins/immunology ; Recombinant Fusion Proteins/genetics ; Recombinant Fusion Proteins/chemistry ; Vaccine Development ; Vaccines, Synthetic/immunology ; Vaccines, Synthetic/administration & dosage ; Vaccines, Synthetic/chemistry

المؤلفون: Seki S; AIDS Research Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan., Parbie PK; AIDS Research Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan; Graduate School of Medical Sciences and Joint Research Center for Human Retrovirus Infection, Kumamoto University, Honjo 2-2-1, Chuo-ku, Kumamoto 860-0811, Japan., Yamamoto H; Graduate School of Medical Sciences and Joint Research Center for Human Retrovirus Infection, Kumamoto University, Honjo 2-2-1, Chuo-ku, Kumamoto 860-0811, Japan; AIDS Research Center, National Institute of Infectious Diseases, 4-7-1 Gakuen, Musashi-Murayama City, Tokyo 208-0011, Japan; Immunodeficiency Laboratory, Department of Biomedicine, University Hospital, 20 Hebelstrasse, Basel 4031, Switzerland. Electronic address: h-yamato@niid.go.jp., Matano T; AIDS Research Center, National Institute of Infectious Diseases, 1-23-1 Toyama, Shinjuku-ku, Tokyo 162-8640, Japan; Graduate School of Medical Sciences and Joint Research Center for Human Retrovirus Infection, Kumamoto University, Honjo 2-2-1, Chuo-ku, Kumamoto 860-0811, Japan; The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. Electronic address: tmatano@niid.go.jp.

المصدر: Journal of biotechnology [J Biotechnol] 2024 Aug 10; Vol. 391, pp. 57-63. Date of Electronic Publication: 2024 Jun 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8411927 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4863 (Electronic) Linking ISSN: 01681656 NLM ISO Abbreviation: J Biotechnol Subsets: MEDLINE

مواضيع طبية MeSH: Immunoglobulin Fc Fragments*/genetics , Immunoglobulin Fc Fragments*/metabolism , Immunoglobulin Fc Fragments*/immunology , Antigen-Presenting Cells*/immunology , Antigen-Presenting Cells*/metabolism , Virion*/metabolism , Virion*/genetics , Dendritic Cells*/immunology , Dendritic Cells*/metabolism, Animals ; Mice ; Macrophages/metabolism ; Macrophages/immunology ; Recombinant Fusion Proteins/genetics ; Recombinant Fusion Proteins/metabolism ; Recombinant Fusion Proteins/immunology ; Simian Immunodeficiency Virus/immunology ; Simian Immunodeficiency Virus/genetics ; Hemagglutinin Glycoproteins, Influenza Virus/immunology ; Hemagglutinin Glycoproteins, Influenza Virus/genetics ; Hemagglutinin Glycoproteins, Influenza Virus/metabolism ; Cell Line ; Leukemia Virus, Murine/genetics ; Phagocytosis ; Humans

المؤلفون: Reusch J; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany., Franken LE; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F.Hoffmann-La Roche Ltd, Basel, Switzerland., Then J; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany., Ringler P; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Basel, F.Hoffmann-La Roche Ltd, Basel, Switzerland.; Biozentrum, University of Basel, Basel, Switzerland., Butzer J; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany., Juroschek T; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany., Klein C; Roche Pharma Research and Early Development, Discovery Oncology, Roche Innovation Center Zurich, Roche Glycart AG, Schlieren, Switzerland., Schlothauer T; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany., Larivière L; Roche Pharma Research and Early Development, Therapeutic Modalities, Roche Innovation Center Munich, Roche Diagnostics GmbH, Penzberg, Germany.

المصدر: Frontiers in immunology [Front Immunol] 2024 Jun 12; Vol. 15, pp. 1401471. Date of Electronic Publication: 2024 Jun 12 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: Ribonucleoproteins*/immunology , Ribonucleoproteins*/metabolism , Protein Binding* , Antibodies, Neutralizing*/immunology , Immunoglobulin Fc Fragments*/immunology , Immunoglobulin Fc Fragments*/metabolism, Humans ; Protein Engineering ; Antibodies, Viral/immunology ; Antibodies, Viral/metabolism ; Antibody Affinity/immunology ; Animals

المؤلفون: Dumet C; EA7501, Université de Tours, 37041 Tours, France.; MAbSilico, 1 Impasse du Palais, 37000 Tours, France., Pugnière M; Institut de Recherche en Cancérologie de Montpellier, Université de Montpellier, 34090 Montpellier, France., Henriquet C; Institut de Recherche en Cancérologie de Montpellier, Université de Montpellier, 34090 Montpellier, France., Gouilleux-Gruart V; EA7501, Université de Tours, 37041 Tours, France.; Laboratoire d'Immunologie, Centre Hospitalier Universitaire, 37044 Tours, France., Poupon A; MAbSilico, 1 Impasse du Palais, 37000 Tours, France.; Physiologie de la Reproduction et des Comportements, INRAE UMR-0085, CNRS UMR-7247, Université de Tours, 37380 Nouzilly, France.; Musca, Inria Saclay-Île-de-France, 91120 Palaiseau, France., Watier H; EA7501, Université de Tours, 37041 Tours, France.; Laboratoire d'Immunologie, Centre Hospitalier Universitaire, 37044 Tours, France.

المصدر: International journal of molecular sciences [Int J Mol Sci] 2023 Mar 16; Vol. 24 (6). Date of Electronic Publication: 2023 Mar 16.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

مواضيع طبية MeSH: Immunoglobulin G* , Receptors, Fc*/metabolism, Antibodies, Monoclonal ; Histocompatibility Antigens Class I ; Mutagenesis ; Protein Binding ; Immunoglobulin Fc Fragments/immunology

المؤلفون: Shaw TM; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA., Huey D; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, 43210, USA.; Viruses and Emerging Pathogens Program, Infectious Diseases Institute, The Ohio State University, Columbus, OH, USA., Mousa-Makky M; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, 43210, USA.; Viruses and Emerging Pathogens Program, Infectious Diseases Institute, The Ohio State University, Columbus, OH, USA., Compaleo J; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, 43210, USA.; Viruses and Emerging Pathogens Program, Infectious Diseases Institute, The Ohio State University, Columbus, OH, USA., Nennig K; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA., Shah AP; Stanford University School of Medicine, Stanford, CA, 94305, USA., Jiang F; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, 43210, USA., Qiu X; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA., Klipsic D; Research Animal Resources and Compliance (RARC), University of Wisconsin-Madison, Madison, WI, USA., Rowland RRR; Department of Pathobiology, College of Veterinary Medicine, University of Illinois Urbana-Champaign, Urbana, IL, USA., Slukvin II; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA., Sullender ME; Division of Infectious Diseases, Department of Medicine, Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine, St. Louis, MO, 63110, USA., Baldridge MT; Division of Infectious Diseases, Department of Medicine, Edison Family Center for Genome Sciences & Systems Biology, Washington University School of Medicine, St. Louis, MO, 63110, USA., Li H; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, 43210, USA.; Department of Surgery, The Ohio State University College of Medicine, Columbus, OH, 43210, USA., Warren CJ; Department of Veterinary Biosciences, The Ohio State University, Columbus, OH, 43210, USA. warren.802@osu.edu.; Viruses and Emerging Pathogens Program, Infectious Diseases Institute, The Ohio State University, Columbus, OH, USA. warren.802@osu.edu.; Center for RNA Biology, The Ohio State University, Columbus, OH, USA. warren.802@osu.edu.; Center for Retrovirus Research, The Ohio State University, Columbus, OH, USA. warren.802@osu.edu., Bailey AL; Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison School of Medicine and Public Health, Madison, WI, USA. albailey@wisc.edu.

المصدر: Nature communications [Nat Commun] 2024 Aug 07; Vol. 15 (1), pp. 6726. Date of Electronic Publication: 2024 Aug 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Fc*/metabolism , Receptors, Fc*/genetics , Histocompatibility Antigens Class I*/metabolism , Histocompatibility Antigens Class I*/genetics , Receptors, Virus*/metabolism , Receptors, Virus*/genetics, Humans ; Animals ; Cell Line ; Virus Internalization ; Antigens, CD/metabolism ; Antigens, CD/genetics ; Receptors, Cell Surface/metabolism ; Receptors, Cell Surface/genetics ; HEK293 Cells

المؤلفون: Beaudoin-Bussières G; Centre de recherche du CHUM, Montréal, Québec H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Québec H2X 0A9, Canada., Finzi A; Centre de recherche du CHUM, Montréal, Québec H2X 0A9, Canada; Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Québec H2X 0A9, Canada. Electronic address: andres.finzi@umontreal.ca.

المصدر: Trends in microbiology [Trends Microbiol] 2024 Aug; Vol. 32 (8), pp. 756-768. Date of Electronic Publication: 2024 Feb 15.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Elsevier Trends Journals Country of Publication: England NLM ID: 9310916 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-4380 (Electronic) Linking ISSN: 0966842X NLM ISO Abbreviation: Trends Microbiol Subsets: MEDLINE

مواضيع طبية MeSH: SARS-CoV-2*/immunology , COVID-19*/immunology , COVID-19*/virology , Antibodies, Viral*/immunology , Antibodies, Neutralizing*/immunology , Antibody-Dependent Cell Cytotoxicity*/immunology , Phagocytosis*/immunology , Immunoglobulin Fc Fragments*/immunology, Humans ; Animals

المؤلفون: Morioka T; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan., Takeuchi M; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan., Ozeki A; Japan Drug Development and Medical Affairs, Eli Lilly Japan K.K., Kobe, Japan., Emoto M; Department of Metabolism, Endocrinology, and Molecular Medicine, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.

المصدر: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Aug; Vol. 26 (8), pp. 3167-3175. Date of Electronic Publication: 2024 May 07.

نوع المنشور: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1463-1326 (Electronic) Linking ISSN: 14628902 NLM ISO Abbreviation: Diabetes Obes Metab Subsets: MEDLINE

مواضيع طبية MeSH: Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/blood , Recombinant Fusion Proteins*/administration & dosage , Recombinant Fusion Proteins*/adverse effects , Recombinant Fusion Proteins*/therapeutic use , Immunoglobulin Fc Fragments*/adverse effects , Immunoglobulin Fc Fragments*/administration & dosage , Immunoglobulin Fc Fragments*/therapeutic use , Glucagon-Like Peptides*/analogs & derivatives , Glucagon-Like Peptides*/administration & dosage , Glucagon-Like Peptides*/adverse effects , Glucagon-Like Peptides*/therapeutic use , Hypoglycemic Agents*/administration & dosage , Hypoglycemic Agents*/adverse effects , Hypoglycemic Agents*/therapeutic use , Glycated Hemoglobin*/metabolism , Glycated Hemoglobin*/analysis , Blood Glucose*/drug effects , Blood Glucose*/metabolism, Humans ; Male ; Middle Aged ; Female ; Double-Blind Method ; Japan ; Aged ; Treatment Outcome ; Adult ; Hypoglycemia/chemically induced ; Hypoglycemia/epidemiology ; Drug Administration Schedule ; East Asian People

المؤلفون: Jabbour S; Thomas Jefferson University, Philadelphia, Pennsylvania., Paik JS; Eli Lilly and Company, Indianapolis, Indiana. Electronic address: paik_jim_s@lilly.com., Aleppo G; Feinberg School of Medicine, Northwestern University, Chicago, Illinois., Sharma P; Eli Lilly and Company, Indianapolis, Indiana., Gomez Valderas E; Eli Lilly and Company, Indianapolis, Indiana., Benneyworth BD; Eli Lilly and Company, Indianapolis, Indiana.

المصدر: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists [Endocr Pract] 2024 Aug; Vol. 30 (8), pp. 701-709. Date of Electronic Publication: 2024 May 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9607439 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1530-891X (Print) Linking ISSN: 1530891X NLM ISO Abbreviation: Endocr Pract Subsets: MEDLINE

مواضيع طبية MeSH: Blood Glucose*/drug effects , Blood Glucose*/analysis , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/blood , Glucagon-Like Peptide-1 Receptor Agonists*/administration & dosage , Glucagon-Like Peptide-1 Receptor Agonists*/adverse effects , Glucagon-Like Peptides*/analogs & derivatives , Glucagon-Like Peptides*/administration & dosage , Glucagon-Like Peptides*/therapeutic use , Glucagon-Like Peptides*/adverse effects , Hypoglycemic Agents*/administration & dosage , Hypoglycemic Agents*/therapeutic use , Hypoglycemic Agents*/adverse effects , Immunoglobulin Fc Fragments*/administration & dosage , Immunoglobulin Fc Fragments*/therapeutic use , Immunoglobulin Fc Fragments*/adverse effects, Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Body Weight/drug effects ; Drug Substitution ; Gastric Inhibitory Polypeptide ; Glucagon-Like Peptide-2 Receptor ; Glycated Hemoglobin/analysis ; Liraglutide/administration & dosage ; Liraglutide/therapeutic use ; Liraglutide/adverse effects ; Prospective Studies ; Recombinant Fusion Proteins/administration & dosage ; Recombinant Fusion Proteins/therapeutic use ; Recombinant Fusion Proteins/adverse effects